These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 22281383

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A, Fujimura M, Shimizu H, Tominaga T.
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [Abstract] [Full Text] [Related]

  • 23. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
    Fujimura M, Kaneta T, Shimizu H, Tominaga T.
    Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Microsurgical neurovascular anastomosis: the example of superficial temporal artery to middle cerebral artery bypass. Technical principles.
    Thines L, Durand A, Penchet G, Proust F, Lenci H, Debailleul A, Lejeune JP, Pelissou-Guyotat I.
    Neurochirurgie; 2014 Aug; 60(4):158-64. PubMed ID: 24856046
    [Abstract] [Full Text] [Related]

  • 29. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA, Armstrong D, Vachhrajani S, Dirks PB.
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [Abstract] [Full Text] [Related]

  • 30. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T.
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [Abstract] [Full Text] [Related]

  • 31. Prevention of the Rerupture of Collateral Artery Aneurysms on the Ventricular Wall by Early Surgical Revascularization in Moyamoya Disease: Report of Two Cases and Review of the Literature.
    Kanamori F, Takasu S, Ota S, Seki Y.
    World Neurosurg; 2018 Jan; 109():393-397. PubMed ID: 29061453
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.
    Zhang W, Wang X, Wang Z, Shang J, Wang H, Yin G.
    World Neurosurg; 2016 Sep; 93():365-70. PubMed ID: 27350298
    [Abstract] [Full Text] [Related]

  • 37. Treatment of Moyamoya Disease and Unruptured Intracranial Aneurysm in Floating-Harbor Syndrome.
    Coughlin DJ, Miller CA, Schuette AJ.
    World Neurosurg; 2017 Aug; 104():1049.e1-1049.e6. PubMed ID: 28549641
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.